News Guizhou Yibai Pharmaceutical Co., Ltd.

Equities

600594

CNE000001H03

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 27/05/2024 am IST			5-day change	1st Jan Change
3.69 ^CNY	-0.81%		-5.87%	-35.15%

18/04	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	YiBai Pharma to Repurchase Up to 40 Million Yuan Shares	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	18/04	CI
YiBai Pharma to Repurchase Up to 40 Million Yuan Shares	30/11	MT
Guizhou Yibai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	30/11	CI
Guizhou Yibai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	29/11	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17/23/17	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
GuiZhou YiBai Pharma to Book 2022 Loss on Policy Changes, COVID-19	25/23/25	MT
Guizhou Yibai Pharmaceutical Completes Construction of $84.5 Million Factory	24/22/24	MT
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Guizhou Yibai Traditional Chinese Medicine Formula Granules Pharmaceutical Co., Ltd. announced that it expects to receive CNY 179.8539 million in funding from Guizhou Yibai Pharmaceutical Co., Ltd., Guizhou Province Agricultural and Rural Modernization Development Equity Investment Fund Partnership	29/22/29	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22/22/22	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22/22/22	CI
Guizhou Yibai Pharmaceutical Co., Ltd. completed the acquisition of 70% stake in Deyang Cancer Hospital Co., Ltd. from Deyang Foji Hospital Management Partnership (Limited Partnership), Deyang Foming Hospital Management Partnership (Limited Partnership) and Deyang Foxiang Management Hospital Partnership (Limited Partnership)	27/21/27	CI
Guizhou Yibai Pharmaceutical Co., Ltd. signed an equity transfer agreement to acquire a 70% stake in Deyang Cancer Hospital Co., Ltd. from Deyang Foji Hospital Management Partnership (Limited Partnership), Deyang Foming Hospital Management Partnership (Limited Partnership) and Deyang Foxiang Management Hospital Partnership (Limited Partnership) for approximately CNY 340 million.	28/21/28	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/21/27	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	26/21/26	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	22/21/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Guizhou Yibai Pharmaceutical Co., Ltd.

Equities

600594

CNE000001H03

Summary

Filters